Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia

PurposeLefamulin is the first pleuromutilin antibiotic approved for the treatment of community-acquired bacterial pneumonia (CABP). However, the pharmacokinetic/pharmacodynamic (PK/PD) characteristics in Chinese CABP patients are not fully understood. This study aimed to evaluate its microbiological...

Full description

Saved in:
Bibliographic Details
Main Authors: Xingchen Bian (Author), Nanyang Li (Author), Yi Li (Author), Xu Zhu (Author), Jicheng Yu (Author), Yingying Hu (Author), Haijing Yang (Author), Qiong Wei (Author), Xiaojie Wu (Author), Jingjing Wang (Author), Guoying Cao (Author), Jufang Wu (Author), Yang Wang (Author), Jing Zhang (Author)
Format: Book
Published: Frontiers Media S.A., 2024-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available